TTNP TITAN PHARMACEUTICALS INC Delisting Actions 8-K Filing 2025 - Nasdaq Notice Titan Pharmaceuticals received a notice from Nasdaq for not holding an annual shareholder meeting within the required timeframe, giving them 45 days to submit a compliance plan to avoid delisting.Get access to all SEC 8-K filings of the TITAN PHARMACEUTICALS INC